BlackRock’s Leap Therapeutics LPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.2K Sell
125,234
-76,431
-38% -$22.7K ﹤0.01% 4970
2025
Q1
$61.5K Sell
201,665
-25,361
-11% -$7.74K ﹤0.01% 4826
2024
Q4
$653K Buy
227,026
+24,063
+12% +$69.2K ﹤0.01% 4292
2024
Q3
$522K Buy
202,963
+30,907
+18% +$79.4K ﹤0.01% 4264
2024
Q2
$337K Buy
172,056
+142,758
+487% +$280K ﹤0.01% 4385
2024
Q1
$77.9K Sell
29,298
-65,858
-69% -$175K ﹤0.01% 4729
2023
Q4
$394K Buy
95,156
+50,373
+112% +$209K ﹤0.01% 4405
2023
Q3
$61.8K Sell
44,783
-3,165
-7% -$4.37K ﹤0.01% 4897
2023
Q2
$150K Sell
47,948
-13,953
-23% -$43.7K ﹤0.01% 4725
2023
Q1
$210K Buy
61,901
+556
+0.9% +$1.89K ﹤0.01% 4671
2022
Q4
$276K Sell
61,345
-56,596
-48% -$255K ﹤0.01% 4676
2022
Q3
$1.04M Sell
117,941
-1,963
-2% -$17.3K ﹤0.01% 4379
2022
Q2
$1.38M Buy
119,904
+85
+0.1% +$977 ﹤0.01% 4313
2022
Q1
$2.1M Buy
119,819
+1,408
+1% +$24.7K ﹤0.01% 4285
2021
Q4
$3.84M Buy
118,411
+98,865
+506% +$3.2M ﹤0.01% 4049
2021
Q3
$784K Sell
19,546
-1,478
-7% -$59.3K ﹤0.01% 4563
2021
Q2
$346K Sell
21,024
-173
-0.8% -$2.85K ﹤0.01% 4711
2021
Q1
$403K Buy
21,197
+1,281
+6% +$24.4K ﹤0.01% 4573
2020
Q4
$448K Buy
19,916
+9,349
+88% +$210K ﹤0.01% 4288
2020
Q3
$209K Buy
10,567
+3,683
+54% +$72.8K ﹤0.01% 4299
2020
Q2
$144K Buy
6,884
+2,989
+77% +$62.5K ﹤0.01% 4345
2020
Q1
$62K Buy
3,895
+690
+22% +$11K ﹤0.01% 4354
2019
Q4
$36K Sell
3,205
-34
-1% -$382 ﹤0.01% 4517
2019
Q3
$38K Sell
3,239
-184
-5% -$2.16K ﹤0.01% 4520
2019
Q2
$61K Buy
3,423
+978
+40% +$17.4K ﹤0.01% 4499
2019
Q1
$45K Buy
2,445
+890
+57% +$16.4K ﹤0.01% 4443
2018
Q4
$31K Sell
1,555
-28
-2% -$558 ﹤0.01% 4490
2018
Q3
$123K Buy
1,583
+64
+4% +$4.97K ﹤0.01% 4359
2018
Q2
$137K Buy
1,519
+492
+48% +$44.4K ﹤0.01% 4344
2018
Q1
$86K Sell
1,027
-26
-2% -$2.18K ﹤0.01% 4318
2017
Q4
$66K Buy
1,053
+42
+4% +$2.63K ﹤0.01% 4338
2017
Q3
$57K Sell
1,011
-58
-5% -$3.27K ﹤0.01% 4388
2017
Q2
$71K Buy
+1,069
New +$71K ﹤0.01% 4398